Breast Reconstruction Market Size, Growth by Product (Breast implant, Tissue Expander, Acellular Dermal Matrix), Procedure (Immediate, Delayed, Revision), Type (Unilateral, Bilateral), End User (Hospitals, Cosmetology Clinics) - Global Forecasts to 2026
The global breast reconstruction market size is projected to reach USD 647 million by 2026, at a CAGR of 2.7%. This industry is experiencing significant growth due to rising incidences of breast cancer, increasing awareness, and the availability of reimbursements.
To know about the assumptions considered for the study, Request for Free Sample Report
Breast Reconstruction Market Growth Dynamics
Drivers: Increasing awareness regarding breast reconstruction treatment
A number of patients opt for breast reconstruction surgery after mastectomy. This can be primarily attributed to the growing concerns and increasing awareness of the safety and efficacy of reconstructive surgeries. This trend can be observed in both developed and emerging countries that are witnessing improvements in the standard of living.
The rise in awareness can be credited to initiatives taken by market players and stakeholders as well as independent bodies such as the American Society of Plastic Surgeons (ASPS). ASPS, along with the Plastic Surgery Foundation, organized the Breast Reconstruction Awareness campaign to engage and educate women on reconstruction post breast cancer diagnosis. The primary aim of the campaign was to educate women, family members, and the media that the breast cancer loop remains open until a woman is informed of her breast reconstruction options. Other key events include the Association of Breast Surgery Conference 2020 in England and the 36th Annual Breast Surgery Symposium held in Georgia, US. In 2011, Canada launched the first BRA Day (Breast Reconstruction Awareness Day). This year, the American Society of Plastic Surgeons and The Plastic Surgery Foundation have joined forces with the Canadians to initiate BRA Day USA. On February 17, 2022, Tata Memorial Center organized a conference - Reconstruction and Cancer Care: Enhancing Quality Living with and Beyond Cancer to create awareness regarding breast reconstruction. In September 2021, the Journal of the American Society of Plastic Surgeons organized the 8th Secondary optimizing Aesthetic Surgery (SOS) Symposium. In November 2021, a meeting was held on the Experienced Insights in Breast and Body Contouring meeting held in Arlington, Texas. On January 28 through 30, 2022, The 37th Annual Atlanta Breast Surgery Symposium was held, in Atlanta, Ga. The upcoming event such as 23rd ASBrS Annual Meeting will be held at Wynn Las Vegas, from April 6–10, 2022 the meeting will focus on Coding and Reimbursement, High-Risk Clinic, Breast Imaging in 2022, Mitigating Disparities in Medicine, The Surgical Innovation Forum, Pain Management in Breast Surgery.
Restraints: Alternative non-surgical methods
After a mastectomy, some women prefer breast reconstruction surgery. Others do not opt for it due to a lack of awareness or other health issues such as obesity, skinniness, or change in blood flow dynamics. These women can opt for alternatives to breast reconstruction, such as custom breast prosthetics and going flat. Custom breast prosthetics can replicate the woman’s exact shape and create symmetry with the intact breast for single-mastectomy patients. These prosthetics are much cheaper than the breast reconstruction process and are available in the range of under USD 100 to USD 500 for high-quality products. The availability of alternatives, especially non-surgical methods, is a key restraint to the breast reconstruction market.
Opportunities: Development of 3D-printed implants
The emergence of 3D-printed implants can provide significant opportunities for market growth. German companies, BellaSeno and Evonik, have entered into a collaboration to develop 3D breast implant technology. BellaSeno will use Evonik’s Resomer bioresorbable polymer in its Senella breast scaffolds, avoiding the use of silicone implants that have raised major safety concerns.
BellaSeno planned to start the first human clinical trials of the Senella scaffolds with Resomer in Germany in 2019. Evonik has supplied its Resomer polymer for clinical and commercial use. The scaffolds are designed to guide the growth of the natural tissue using the patient's body fat harvested via liposuction. This product is designed to be used after augmentation, reconstruction, and revision surgery. This is progressively reabsorbed by the body and replaced with natural breast tissue. This technology avoids the use of silicone implants and their associated complications & risk, like capsular contracture, rupture, and deflation. Moreover, in December 2021, Bellaseno GmbH reported the publication of first-in-human data for its 3D-printed biodegradable and highly porous Senella scaffold filled with an autologous fat graft to correct a chest deformation in a 22-year-old patient with severe pectus excavatum. The article was published in the European Journal of Plastic Surgery.
Challenges: Product failures and recalls
Product failures due to malfunctioning can have severe or even fatal complications. Over the years, several products have been recalled from the market due to malfunctions or other issues. Such recalls can harm the end-user perception of the safety of these devices and affect their adoption. For instance, in 2019, Allergan (US) recalled its Biocell textured breast implants and tissue expanders after they were linked to anaplastic large-cell lymphoma (ALCL). In 2016, Mentor (US) recalled its Mentor MemoryGel Breast Implant as the box of 300cc MemoryGel Breast Implant was labeled with null manufacturing and expiration dates.
The breast implants segment is expected to dominate the breast reconstruction market
Based on the product, the market industry is segmented into breast implants, tissue expanders, and acellular dermal matrix. The breast implants segment accounted for the largest market share in 2020. This is primarily attributed to the increasing incidences of breast cancer and the rising number of breast reconstruction procedures.
Silicone implants hold the largest share of the market for breast implants
The breast implants market is segmented into silicone and saline implants. Silicone implants accounted for the largest market share in 2020 due to the large number of silicone breast implantation procedures performed across the globe.
To know about the assumptions considered for the study, download the pdf brochure
North America was the largest regional market for breast reconstruction in 2020
The breast reconstruction market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2020, North America held the largest share of the market, followed by Europe. The rising incidences of breast cancer, increasing awareness of breast reconstruction, and FDA approvals for breast reconstruction products in this region are the major factors driving the growth of the breast reconstruction in North America.
Breast Reconstruction Market Key Players
The prominent players operating in this market include Mentor Worldwide LLC (Johnson & Johnson) (US), are Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), Silimed (Brazil), Laboratories Arion (France), and other players are Guangzhou Wanhe Plastic Materials Co. Ltd.(China), CEREPLAS (France), HansBiomed (South Korea), PMT Corporation (US), and Shanghai Kangning Medical Device (China)
Mentor Worldwide LLC (Johnson & Johnson) (US) is one of the leading players in the breast reconstruction market. The company offers a broad product portfolio across the globe. Over the years, the company has maintained its leading position in the market.
Scope of the Breast Reconstruction Market Report
|
Report Metrics |
Details |
|
Market Size value 2026 |
USD 647 million |
|
Growth Rate |
2.7% CAGR |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Opportunities, Restraints & Challenges |
|
Largest Share Segments |
Breast Implants - Silicon implants |
|
Forecasts up to |
2026 |
|
Market Segmentation |
Product, Procedure, Type, End User and Region |
|
Breast Reconstruction Market Growth Drivers |
|
|
Breast Reconstruction Market Growth Opportunities |
|
|
Geographies covered |
North America, Europe, APAC, MEA, and Latin America |
Report categorizes the global breast reconstruction market into the following segments and subsegments:
By Product
-
Breast Implants
-
By Type
- Silicone Implants
- Saline Implants
-
Shape
- Round Implants
- Anatomical Implants
- Tissue Expanders
- Acellular Dermal Matrix
-
By Type
By Procedure
- Immediate
- Delayed
- Revision
By Type
- Unilateral
- Bilateral
By End User
- Hospitals
- Cosmetology Clinics and Ambulatory Surgical Centers
By Region
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- RoE
-
Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Rest of the World
Recent Developments
- In 2022, Mentor Worldwide LLC (Johnson & Johnson) received the US FDA approved a new MENTOR Memory Gel boost breast implant
- In 2021, POLYTECH Health & Aesthetics received US FDA approval for the company’s textured breast implants (macrotextured and polyurethane-coated implants)
- In 2020, Sientra received US FDA pre-market approval for its OPUS-branded breast implant products
Frequently Asked Questions (FAQ):
What is the size of Breast Reconstruction Market ?
The Breast Reconstruction Market size is projected to reach USD 647 Million by 2026, growing at a CAGR of 2.7%.
What are the major growth factors of Breast Reconstruction Market ?
This industry is experiencing significant growth due to rising incidences of breast cancer, increasing awareness, and the availability of reimbursements.
Who all are the prominent players of Breast Reconstruction Market ?
The prominent players operating in the global breast reconstruction market are Mentor Worldwide LLC (Johnson & Johnson) (US), Allergan Aesthetics (an Abbvie company) (US), Ideal Implant Incorporated (US), Sebbin (France), GC Aesthetics (Ireland), POLYTECH Health & Aesthetics (Germany), Sientra (US), Integra Lifesciences (US), RTI Surgical Holdings (US), Establishment Labs S.A. (US), and Silimed (Brazil).
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 37)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
TABLE 1 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 42)
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Secondary sources
2.1.2 PRIMARY DATA
FIGURE 2 PRIMARY SOURCES
2.1.2.1 Key data from primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primary interviews: By company type, designation, and region
2.2 MARKET SIZE ESTIMATION
FIGURE 3 REVENUE SHARE ANALYSIS ILLUSTRATION: SIENTRA.
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF BREAST RECONSTRUCTION PRODUCTS AND SERVICES
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 6 TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN & DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.6 LIMITATIONS
2.6.1 METHODOLOGY-RELATED LIMITATIONS
2.7 RISK ASSESSMENT
TABLE 2 RISK ASSESSMENT: BREAST RECONSTRUCTION MARKET
2.8 COVID-19 HEALTH ASSESSMENT
2.9 COVID-19 ECONOMIC ASSESSMENT
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3 EXECUTIVE SUMMARY (Page No. - 58)
FIGURE 10 BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION)
FIGURE 11 MARKET, BY PROCEDURE, 2021 VS. 2026 (USD MILLION)
FIGURE 12 MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 13 MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
FIGURE 14 BREAST RECONSTRUCTION MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4 PREMIUM INSIGHTS (Page No. - 62)
4.1 BREAST RECONSTRUCTION MARKET OVERVIEW
FIGURE 15 RISING INCIDENCES OF BREAST CANCER EXPECTED TO DRIVE THE GROWTH OF THE MARKET DURING THE FORECAST PERIOD
4.2 BREAST RECONSTRUCTION BREAST IMPLANTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
FIGURE 16 SILICONE IMPLANT SEGMENT TO GROW AT A CAGR DURING HE FORECAST PERIOD
4.3 NORTH AMERICA: MARKET, BY PRODUCT AND COUNTRY (2020)
FIGURE 17 BREAST IMPLANTS ACCOUNTED FOR THE LARGEST MARKET SHARE IN 2020
4.4 MARKET, BY PROCEDURE, 2021–2026
FIGURE 18 IMMEDIATE PROCEDURE SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD (2021-2026)
4.5 BREAST RECONSTRUCTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 THE MARKET IN CHINA EXPECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
5 MARKET OVERVIEW (Page No. - 66)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 BREAST RECONSTRUCTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of breast cancer
TABLE 3 TOP 10 COUNTRIES WITH THE HIGHEST INCIDENCE OF BREAST CANCER, 2020
TABLE 4 INCIDENCE OF BREAST CANCER, 2018 VS. 2020 VS. 2025
5.2.1.2 Growing aging population
5.2.1.3 Increasing awareness regarding breast reconstruction treatment
5.2.1.4 Improving reimbursements for breast reconstruction procedures
TABLE 5 CPT CODES FOR BREAST RECONSTRUCTION
5.2.2 RESTRAINTS
5.2.2.1 Clinical risks and complications of breast reconstruction procedures
5.2.2.2 Alternative non-surgical methods
5.2.3 OPPORTUNITIES
5.2.4 HIGH MARKET GROWTH POTENTIAL IN EMERGING ECONOMIES
5.2.4.1 Development of 3D-printed implants
5.2.4.2 Rise in preference for biological products
5.2.5 CHALLENGES
5.2.5.1 Product failures and recalls
5.2.5.2 Dearth of trained professionals
5.2.6 COVID-19 IMPACT ON THE BREAST RECONSTRUCTION MARKET
5.3 RANGES/SCENARIOS
5.3.1 BREAST RECONSTRUCTION MARKET
FIGURE 21 PESSIMISTIC SCENARIO
FIGURE 22 OPTIMISTIC SCENARIO
FIGURE 23 REALISTIC SCENARIO
5.4 TARIFF AND REGULATORY LANDSCAPE
5.4.1 NORTH AMERICA
5.4.1.1 US
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 Canada
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
TABLE 9 BREAST LESION LOCALIZATION DEVICES CLASSIFICATION ACCORDING TO THE GOVERNMENT OF CANADA
5.4.2 EUROPE
FIGURE 24 EUROPE: CLASS III MEDICAL DEVICES
5.4.3 ASIA PACIFIC
5.4.3.1 Japan
TABLE 10 JAPAN: CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY
5.4.3.2 China
TABLE 11 NMPA MEDICAL DEVICES CLASSIFICATION
5.4.3.3 India
5.5 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 BREAST RECONSTRUCTION MARKET: PORTER’S FIVE FORCES ANALYSIS
5.5.1 INTENSITY OF COMPETITIVE RIVALRY
5.5.2 BARGAINING POWER OF SUPPLIERS
5.5.3 BARGAINING POWER OF BUYERS
5.5.4 THREAT OF SUBSTITUTES
5.5.5 THREAT OF NEW ENTRANTS
5.6 TECHNOLOGY ANALYSIS
5.7 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS FOR THE BREAST RECONSTRUCTION MARKET
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 26 DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES
5.9 PATENT ANALYSIS
5.9.1 PATENT GRANTED TRENDS FOR BREAST RECONSTRUCTION
FIGURE 27 PATENT GRANTED TRENDS OF BREAST IMPLANTS, JANUARY 2011–FEBRUARY 2022
FIGURE 28 PATENT GRANTED TRENDS OF ACELLULAR DERMAL MATRIX, JANUARY 2011– FEBRUARY 2022
5.9.2 JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 29 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR BREAST IMPLANTS PATENTS, JANUARY 2011—FEBRUARY 2022
FIGURE 30 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR ACELLULAR DERMAL MATRIX, JANUARY 2011—FEBRUARY 2022
5.10 TRADE ANALYSIS
TABLE 13 IMPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION)
TABLE 14 EXPORT DATA FOR HS CODE 902190 - ARTICLES AND APPLIANCES, WHICH ARE WORN OR CARRIED, OR IMPLANTED IN THE BODY, TO COMPENSATE FOR A DEFECT OR DISABILITY (EXCLUDING ARTIFICIAL PARTS OF THE BODY, COMPLETE HEARING AIDS, AND COMPLETE PACEMAKERS FOR STIMULATING HEART MUSCLES), BY COUNTRY, 2016–2020 (USD MILLION)
5.11 PRICING ANALYSIS
TABLE 15 PRICE OF BREAST RECONSTRUCTION PRODUCTS (USD)
TABLE 16 AVERAGE COST OF BREAST RECONSTRUCTION SURGERY USING IMPLANTS (USD)
5.12 KEY CONFERENCES & EVENTS IN 2022-2023
TABLE 17 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF CONFERENCES & EVENTS
5.13 ECOSYSTEM ANALYSIS
FIGURE 31 ECOSYSTEM OF THE BREAST HEALTH INDUSTRY
5.13.1 ROLE IN THE ECOSYSTEM
FIGURE 32 KEY PLAYERS IN THE BREAST RECONSTRUCTION ECOSYSTEM
5.14 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.14.1 REVENUE SHIFT & REVENUE POCKETS FOR BREAST RECONSTRUCTION PRODUCTS MANUFACTURERS OR SERVICE PROVIDERS
FIGURE 33 REVENUE SHIFT FOR BREAST RECONSTRUCTION PRODUCTS
6 BREAST RECONSTRUCTION MARKET, BY PRODUCT (Page No. - 95)
6.1 INTRODUCTION
TABLE 18 US: PRODUCTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020
TABLE 19 MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 20 MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
6.2 BREAST IMPLANT
TABLE 21 US: TYPES OF BREAST IMPLANTS USED FOR BREAST RECONSTRUCTION PROCEDURES, 2020
TABLE 22 MARKET FOR BREAST IMPLANT, BY REGION, 2018–2020 (USD MILLION)
TABLE 23 MARKET FOR BREAST IMPLANT, BY REGION, 2021–2026 (USD MILLION)
6.2.1 BREAST IMPLANTS MARKET, BY TYPE
TABLE 24 MARKET FOR BREAST IMPLANT, BY TYPE, 2018–2020 (USD MILLION)
TABLE 25 MARKET FOR BREAST IMPLANT, BY TYPE, 2021–2026 (USD MILLION)
6.2.1.1 Silicone implants
6.2.1.1.1 Silicone breast implants expected to dominate the breast implants market due to their benefits
TABLE 26 SILICONE BREAST IMPLANTS MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 27 SILICONE BREAST IMPLANTS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.1.2 Saline Implants
6.2.1.2.1 Low cost of implants to drive market growth
TABLE 28 SALINE IMPLANTS MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 29 SALINE IMPLANTS MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.2 BREAST IMPLANTS MARKET, BY SHAPE
TABLE 30 MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 31 BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
6.2.2.1 Round implants
6.2.2.1.1 Round implants show the highest end-user demand and market growth
TABLE 32 ROUND BREAST IMPLANT MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 33 ROUND BREAST IMPLANT MARKET, BY REGION, 2021–2026 (USD MILLION)
6.2.2.2 Anatomical implants
6.2.2.2.1 Increasing implant-based breast reconstruction procedures will support the market growth
TABLE 34 ANATOMICAL BREAST IMPLANT MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 35 ANATOMICAL BREAST IMPLANT MARKET, BY REGION, 2021–2026 (USD MILLION)
6.3 TISSUE EXPANDER
6.3.1 RISING NUMBER OF BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH
TABLE 36 BREAST RECONSTRUCTION MARKET FOR TISSUE EXPANDER, BY REGION, 2018–2020 (USD MILLION)
TABLE 37 MARKET FOR TISSUE EXPANDER, BY REGION, 2021–2026 (USD MILLION)
6.4 ACELLULAR DERMAL MATRIX
6.4.1 RISING NUMBER OF ACELLULAR DERMAL MATRIX BREAST RECONSTRUCTION PROCEDURES WILL SUPPORT MARKET GROWTH
TABLE 38 MARKET FOR ACELLULAR DERMAL MATRIX, BY REGION, 2018–2020 (USD MILLION)
TABLE 39 BREAST RECONSTRUCTION MARKET FOR ACELLULAR DERMAL MATRIX, BY REGION, 2021–2026 (USD MILLION)
7 BREAST RECONSTRUCTION MARKET, BY PROCEDURE (Page No. - 106)
7.1 INTRODUCTION
TABLE 40 US: IMMEDIATE AND DELAYED BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020
TABLE 41 MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 42 MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
7.2 IMMEDIATE PROCEDURES
7.2.1 IMMEDIATE PROCEDURES WAS THE LARGEST MARKET SEGMENT
TABLE 43 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 44 IMMEDIATE BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION)
7.3 DELAYED PROCEDURES
7.3.1 RISING AWARENESS WILL SUPPORT MARKET GROWTH
TABLE 45 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 46 DELAYED BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION)
7.4 REVISION PROCEDURES
7.4.1 DISSATISFACTION AND AESTHETIC ISSUES DRIVE DEMAND FOR REVISION
TABLE 47 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 48 REVISION BREAST RECONSTRUCTION PROCEDURES MARKET, BY REGION, 2021–2026 (USD MILLION)
8 BREAST RECONSTRUCTION MARKET, BY TYPE (Page No. - 112)
8.1 INTRODUCTION
TABLE 49 US: UNILATERAL AND BILATERAL BREAST RECONSTRUCTION PROCEDURES PERFORMED, 2020
TABLE 50 MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 51 MARKET, BY TYPE, 2021–2026 (USD MILLION)
8.2 UNILATERAL BREAST RECONSTRUCTION
8.2.1 UNILATERAL RECONSTRUCTION DOMINATES THE MARKET, BY TYPE
TABLE 52 MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 53 MARKET, BY REGION, 2021–2026 (USD MILLION)
8.3 BILATERAL
8.3.1 APAC TO SHOW HIGHEST GROWTH IN THE MARKET FOR BILATERAL BREAST RECONSTRUCTION
TABLE 54 MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 55 MARKET, BY REGION, 2021–2026 (USD MILLION)
9 BREAST RECONSTRUCTION MARKET, BY END USER (Page No. - 116)
9.1 INTRODUCTION
TABLE 56 MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 57 MARKET, BY END USER, 2021–2026 (USD MILLION)
9.2 HOSPITALS
9.2.1 HOSPITALS TO DOMINATE THE BREAST RECONSTRUCTION MARKET DURING THE FORECAST PERIOD
TABLE 58 MARKET FOR HOSPITALS, BY REGION, 2018–2020 (USD MILLION)
TABLE 59 MARKET FOR HOSPITALS, BY REGION, 2021–2026 (USD MILLION)
9.3 COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS
9.3.1 GROWING PREFERENCE FOR OUTPATIENT TREATMENT AND PROCEDURES OVER HOSPITAL CARE DRIVES MARKET GROWTH
TABLE 60 MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2020 (USD MILLION)
TABLE 61 MARKET FOR COSMETOLOGY CLINICS & AMBULATORY SURGICAL CENTERS, BY REGION, 2021–2026 (USD MILLION)
9.4 COVID-19 ANALYSIS
10 BREAST RECONSTRUCTION MARKET, BY REGION (Page No. - 121)
10.1 INTRODUCTION
TABLE 62 MARKET, BY REGION, 2018–2020 (USD MILLION)
TABLE 63 MARKET, BY REGION, 2021–2026 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: MARKET SNAPSHOT
TABLE 64 NORTH AMERICA: MARKET, BY COUNTRY, 2018–2020 (USD MILLION)
TABLE 65 NORTH AMERICA: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 66 NORTH AMERICA: MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 67 NORTH AMERICA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 68 NORTH AMERICA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 69 NORTH AMERICA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 70 NORTH AMERICA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 71 NORTH AMERICA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 72 NORTH AMERICA: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 73 NORTH AMERICA: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 74 NORTH AMERICA: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 75 NORTH AMERICA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 76 NORTH AMERICA: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 77 NORTH AMERICA: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.2.1 US
10.2.1.1 The US dominates the North American breast reconstruction market
TABLE 78 US: BREAST RECONSTRUCTIVE PROCEDURES PERFORMED IN 2020, BY TYPE
TABLE 79 US: MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 80 US: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 81 US: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 82 US: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 83 US: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 84 US: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 85 US: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 86 US: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 87 US: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 88 US: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 89 US: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 90 US: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.2.2 CANADA
10.2.2.1 Increasing incidence of breast cancer will drive market growth in Canada
TABLE 91 CANADA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 92 CANADA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 93 CANADA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 94 CANADA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 95 CANADA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 96 CANADA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 97 CANADA: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 98 CANADA: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 99 CANADA: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 100 CANADA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 101 CANADA: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 102 CANADA: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3 EUROPE
TABLE 103 INCIDENCE OF BREAST CANCER IN EUROPEAN COUNTRIES, 2020 VS. 2040
TABLE 104 MASTECTOMY SURGERIES PERFORMED IN EUROPE, BY COUNTRY, 2019
TABLE 105 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2018–2020 (USD MILLION)
TABLE 106 EUROPE: BREAST RECONSTRUCTION MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 107 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 108 EUROPE: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 109 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 110 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 111 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 112 EUROPE: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 113 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 114 EUROPE: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 115 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 116 EUROPE: BREAST RECONSTRUCTION MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 117 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 118 EUROPE: BREAST RECONSTRUCTION MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 Germany dominates the European breast reconstruction market
TABLE 119 GERMANY: BREAST CANCER INCIDENCE, 2018 VS. 2025
TABLE 120 GERMANY: MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 121 GERMANY: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 122 GERMANY: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 123 GERMANY: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 124 GERMANY: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 125 GERMANY: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 126 GERMANY: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 127 GERMANY: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 128 GERMANY: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 129 GERMANY: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 130 GERMANY: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 131 GERMANY: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 Rising geriatric population will drive market growth
TABLE 132 FRANCE: BREAST CANCER INCIDENCE, 2018 VS. 2025
TABLE 133 FRANCE: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 134 FRANCE: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 135 FRANCE: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 136 FRANCE: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 137 FRANCE: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 138 FRANCE: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 139 FRANCE: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 140 FRANCE: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 141 FRANCE: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 142 FRANCE: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 143 FRANCE: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 144 FRANCE: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.3 UK
10.3.3.1 Rising incidences of breast cancer will support market growth
TABLE 145 UK: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 146 UK: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 147 UK: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 148 UK: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 149 UK: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 150 UK: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 151 UK: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 152 UK: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 153 UK: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 154 UK: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 155 UK: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 156 UK: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.4 ITALY
10.3.4.1 Rising geriatric population in Italy to drive the market
TABLE 157 ITALY: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 158 ITALY: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 159 ITALY: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 160 ITALY: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 161 ITALY: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 162 ITALY: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 163 ITALY: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 164 ITALY: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 165 ITALY: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 166 ITALY: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 167 ITALY: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 168 ITALY: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 Silicone implants show high acceptance in Spain
TABLE 169 SPAIN: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 170 SPAIN: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 171 SPAIN: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 172 SPAIN: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 173 SPAIN: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 174 SPAIN: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 175 SPAIN: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 176 SPAIN: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 177 SPAIN: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 178 SPAIN: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 179 SPAIN: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 180 SPAIN: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.3.6 REST OF EUROPE
TABLE 181 ROE: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040
TABLE 182 ROE: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 183 ROE: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 184 ROE: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 185 ROE: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 186 ROE: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 187 ROE: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 188 ROE: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 189 ROE: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 190 ROE: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 191 ROE: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 192 ROE: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 193 ROE: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: BREAST RECONSTRUCTION MARKET SNAPSHOT
TABLE 194 APAC: MARKET, BY COUNTRY, 2018–2020 (USD MILLION)
TABLE 195 APAC: MARKET, BY COUNTRY, 2021–2026 (USD MILLION)
TABLE 196 APAC: MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 197 APAC: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 198 APAC: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 199 APAC: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 200 APAC: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 201 APAC: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 202 APAC: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 203 APAC: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 204 APAC: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 205 APAC: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 206 APAC: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 207 APAC: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.4.1 CHINA
10.4.1.1 China accounts for the largest share of the APAC market
TABLE 208 CHINA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 209 CHINA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 210 CHINA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 211 CHINA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 212 CHINA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 213 CHINA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 214 CHINA: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 215 CHINA: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 216 CHINA: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 217 CHINA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 218 CHINA: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 219 CHINA: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 Growing awareness of cosmetic surgery to drive the market in Japan
TABLE 220 JAPAN: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 221 JAPAN: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 222 JAPAN: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 223 JAPAN: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 224 JAPAN: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 225 JAPAN: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 226 JAPAN: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 227 JAPAN: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 228 JAPAN: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 229 JAPAN: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 230 JAPAN: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 231 JAPAN: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.4.3 INDIA
10.4.3.1 Market growth in India is primarily driven by the rising incidence of breast cancer
TABLE 232 INDIA: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 233 INDIA: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 234 INDIA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 235 INDIA: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 236 INDIA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 237 INDIA: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 238 INDIA: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 239 INDIA: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 240 INDIA: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 241 INDIA: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 242 INDIA: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 243 INDIA: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.4.4 REST OF ASIA PACIFIC
TABLE 244 ROAPAC: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 245 ROAPAC: MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 246 ROAPAC: MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 247 ROAPAC: MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 248 ROAPAC: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 249 ROAPAC: MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 250 ROAPAC: MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 251 ROAPAC: MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 252 ROAPAC: MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 253 ROAPAC: MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 254 ROAPAC: MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 255 ROAPAC: MARKET, BY END USER, 2021–2026 (USD MILLION)
10.5 REST OF THE WORLD
TABLE 256 ROW: BREAST CANCER INCIDENCE, BY COUNTRY, 2020 VS. 2040
TABLE 257 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2018–2020 (USD MILLION)
TABLE 258 ROW: BREAST RECONSTRUCTION MARKET, BY PRODUCT, 2021–2026 (USD MILLION)
TABLE 259 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2018–2020 (USD MILLION)
TABLE 260 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY TYPE, 2021–2026 (USD MILLION)
TABLE 261 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2018–2020 (USD MILLION)
TABLE 262 ROW: BREAST RECONSTRUCTION MARKET FOR BREAST IMPLANTS, BY SHAPE, 2021–2026 (USD MILLION)
TABLE 263 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2018–2020 (USD MILLION)
TABLE 264 ROW: BREAST RECONSTRUCTION MARKET, BY PROCEDURE, 2021–2026 (USD MILLION)
TABLE 265 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE, 2018–2020 (USD MILLION)
TABLE 266 ROW: BREAST RECONSTRUCTION MARKET, BY TYPE, 2021–2026 (USD MILLION)
TABLE 267 ROW: BREAST RECONSTRUCTION MARKET, BY END USER, 2018–2020 (USD MILLION)
TABLE 268 ROW: BREAST RECONSTRUCTION MARKET, BY END USER, 2021–2026 (USD MILLION)
11 COMPETITIVE LANDSCAPE (Page No. - 196)
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 269 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET
11.3 REVENUE SHARE ANALYSIS
FIGURE 36 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN THE BREAST RECONSTRUCTION MARKET
11.4 MARKET SHARE ANALYSIS
FIGURE 37 BREAST RECONSTRUCTION MARKET SHARE ANALYSIS, BY KEY PLAYER, 2020
TABLE 270 BREAST RECONSTRUCTION MARKET: DEGREE OF COMPETITION
11.5 COMPETITIVE LEADERSHIP MAPPING
FIGURE 38 BREAST RECONSTRUCTION MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)
11.6 COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS
FIGURE 39 BREAST RECONSTRUCTION MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES & START-UPS (2020)
11.7 COMPANY FOOTPRINT
TABLE 271 COMPANY FOOTPRINT
TABLE 272 COMPANY PRODUCT FOOTPRINT
TABLE 273 COMPANY REGIONAL FOOTPRINT
11.8 COMPETITIVE BENCHMARKING
TABLE 274 BREAST RECONSTRUCTION MARKET: DETAILED LIST OF KEY START-UPS/SMES
11.9 COMPETITIVE SCENARIO
TABLE 275 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2018– FEBRUARY 2022
TABLE 276 KEY DEALS, JANUARY 2018– FEBRUARY 2022
TABLE 277 OTHER KEY DEVELOPMENTS, JANUARY 2018– FEBRUARY 2022
12 COMPANY PROFILES (Page No. - 211)
12.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON)
TABLE 278 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): BUSINESS OVERVIEW
FIGURE 40 MENTOR WORLDWIDE LLC (JOHNSON & JOHNSON): COMPANY SNAPSHOT (2020)
12.1.2 ALLERGAN AESTHETICS (AN ABBVIE COMPANY)
TABLE 279 ALLERGAN AESTHETICS (AN ABBVIE COMPANY): BUSINESS OVERVIEW
FIGURE 41 ALLERGAN AESTHETICS (AN ABBVIE COMPANY): COMPANY SNAPSHOT (2020)
12.1.3 RECENT DEVELOPMENTS
12.1.4 SIENTRA
TABLE 280 SIENTRA: BUSINESS OVERVIEW
FIGURE 42 SIENTRA: COMPANY SNAPSHOT (2020)
12.1.5 POLYTECH HEALTH & AESTHETICS GMBH
TABLE 281 POLYTECH HEALTH & AESTHETICS: BUSINESS OVERVIEW
12.1.6 RECENT DEVELOPMENTS
12.1.7 GC AESTHETICS
TABLE 282 GC AESTHETICS: BUSINESS OVERVIEW
12.1.8 SEBBIN
TABLE 283 SEBBIN: BUSINESS OVERVIEW
12.1.9 ESTABLISHMENT LABS S.A.
TABLE 284 ESTABLISHMENT LABS HOLDINGS: BUSINESS OVERVIEW
FIGURE 43 ESTABLISHMENT LABS HOLDINGS: COMPANY SNAPSHOT (2020)
12.1.10 INTEGRA LIFESCIENCES
TABLE 285 INTEGRA LIFESCIENCES: BUSINESS OVERVIEW
FIGURE 44 INTEGRA LIFESCIENCES: COMPANY SNAPSHOT (2020)
12.1.11 RTI SURGICAL HOLDINGS
TABLE 286 RTI SURGICAL HOLDINGS: BUSINESS OVERVIEW
FIGURE 45 RTI SURGICAL HOLDINGS: COMPANY SNAPSHOT (2018)
12.1.12 IDEAL IMPLANT INCORPORATED
TABLE 287 IDEAL IMPLANT INCORPORATED: BUSINESS OVERVIEW
12.1.13 LABORATORIES ARION
TABLE 288 LABORATORIES ARION: BUSINESS OVERVIEW
12.1.14 SILIMED
TABLE 289 SILIMED: BUSINESS OVERVIEW
12.1.15 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD.
TABLE 290 GUANGZHOU WANHE PLASTIC MATERIALS CO. LTD.: BUSINESS OVERVIEW
12.1.16 CEREPLAS
TABLE 291 CEREPLAS: BUSINESS OVERVIEW
12.1.17 HANSBIOMED
TABLE 292 HANSBIOMED: BUSINESS OVERVIEW
12.1.18 PRODUCTS OFFERED
12.2 OTHER PLAYERS
12.2.1 SHANGHAI KANGNING MEDICAL DEVICE
12.2.2 PMT CORPORATION
12.2.3 PFM MEDICAL
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX (Page No. - 244)
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 AVAILABLE CUSTOMIZATIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
The study involved four major activities in estimating the current size of the breast reconstruction market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Then, both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
Secondary Research
The secondary sources referred to for this research study on the breast reconstruction market include publications from government sources such as white papers; articles from recognized authors; gold standard and silver standard websites, directories, and databases; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; research journals; press releases; and trade, business, and professional associations.
Primary Research
The breast reconstruction market comprises several stakeholders, such as breast reconstruction product manufacturers and distributors. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the breast reconstruction market. These methods were also used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research.
- The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
Data Triangulation
After arriving at the overall breast reconstruction market size-using the market size estimation processes explained above-the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the breast reconstruction industry.
Report Objectives
- To define, describe, segment, and forecast the breast reconstruction market
- To forecast the size of the market with respect to the main regional segments—North America, Europe, the Asia Pacific, and the Rest of the World
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
- To track and analyze competitive developments such as collaborations, regulatory approvals, partnerships, acquisitions, and product launches in the breast reconstruction market
Available Customizations
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the breast reconstruction market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Company Information:
- Detailed analysis and profiling of additional market players (Up to 5)
Growth opportunities and latent adjacency in Breast Reconstruction Market
How emerging markets offering revenue expansion opportunities in Breast Reconstruction Market?
Which are the most innovative companies in Breast Reconstruction Market?
Which market segment is expected to shape the future of the Breast Reconstruction Market?